The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech companies like Recursion to raise capital. The company reported less-than ...

[Recursion] Recursion said it will end development for four of its 11 pipeline programs—one of which the company will consider outlicensing to a partner instead—and pause a fifth program ...

The Max Extra Member ... to grow subscriber numbers. Netflix is the biggest service to do it to date, at $6.99 a month. The Max Help Center has a page dedicated to the new program if you want ...

This week, the NFL announced an expansion of the Global Markets Program (GMP), with four new teams added as well as two new markets added. The GMP awards teams international marketing rights in ...

With the victory, Penn State advances to the Frozen Four semi-finals for the first time in program history. It’s a huge accomplishment for the program that has existed at the Division I level ...

and macOS Sequoia 15.4 for AirPods Max with USB-C. Apple also said that today it is making a USB-C to 3.5mm audio cable available to buy for $39 from its online store, Apple Store app, and ...

Apple USB-C to 3.5 mm Audio Cable $39 at Apple The advantage of the AirPods Max with USB-C is that you can use the included USB-C charging cable to connect the headphones to your USB-C-equipped PC ...

There are student beneficiaries of the Senior High School Voucher Program who have several learner reference numbers and are enrolled in multiple private schools, according to the Private Education ...

Recursion is involved in a number of ML model developments ... an “external use option” for 12 Phenomaps, $300M maximum per clinical program up to 40 programs (see previous sections for ...

Meanwhile the current market capitalization values the company at $2.4 billion, a lofty number for a largely unproven technology. The good news is that Recursion maintains ample balance sheet ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2024 Earnings Call Transcript February 28, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.53 EPS ...